Financials Meihao Medical Group Co., Ltd
Equities
1947
KYG5966K1094
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.39 HKD | -2.50% |
|
0.00% | -10.34% |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 262.3 | 237.2 |
Enterprise Value (EV) 1 | 209.4 | 129 |
P/E ratio | 7.03 x | -17.5 x |
Yield | - | 2.3% |
Capitalization / Revenue | 2.06 x | 3.23 x |
EV / Revenue | 1.64 x | 1.75 x |
EV / EBITDA | 5.34 x | -35.3 x |
EV / FCF | -4,040,528 x | 1,786,314 x |
FCF Yield | -0% | 0% |
Price to Book | 1.48 x | 1.44 x |
Nbr of stocks (in thousands) | 600,000 | 600,000 |
Reference price 2 | 0.4372 | 0.3954 |
Announcement Date | 24/04/23 | 26/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 83.16 | 84.56 | 105.3 | 127.4 | 73.51 |
EBITDA 1 | 27.28 | 29.2 | 49.13 | 39.2 | -3.658 |
EBIT 1 | 23.77 | 25.31 | 44.64 | 33.07 | -10.94 |
Operating Margin | 28.58% | 29.94% | 42.38% | 25.95% | -14.89% |
Earnings before Tax (EBT) 1 | 23.08 | 24.19 | 43.67 | 40.2 | -7.158 |
Net income 1 | 15.43 | 14.9 | 32.07 | 28.46 | -13.59 |
Net margin | 18.55% | 17.63% | 30.45% | 22.33% | -18.49% |
EPS | - | - | 0.0713 | 0.0622 | -0.0227 |
Free Cash Flow | - | -7.73 | 22.44 | -51.82 | 72.2 |
FCF margin | - | -9.14% | 21.31% | -40.67% | 98.22% |
FCF Conversion (EBITDA) | - | - | 45.67% | - | - |
FCF Conversion (Net income) | - | - | 69.97% | - | - |
Dividend per Share | - | - | - | - | 0.009077 |
Announcement Date | 29/11/22 | 29/11/22 | 29/11/22 | 24/04/23 | 26/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | - | - | 3.26 | - | - |
Net Cash position 1 | 27.1 | 4.5 | - | 52.9 | 108 |
Leverage (Debt/EBITDA) | - | - | 0.0663 x | - | - |
Free Cash Flow | - | -7.73 | 22.4 | -51.8 | 72.2 |
ROE (net income / shareholders' equity) | - | 78.4% | 93.4% | 25% | -7.93% |
ROA (Net income/ Total Assets) | - | 16% | 24% | 10.7% | -2.82% |
Assets 1 | - | 93.01 | 133.5 | 266.1 | 482.1 |
Book Value Per Share | - | - | 0.1100 | 0.3000 | 0.2800 |
Cash Flow per Share | - | - | 0.0900 | 0.1500 | 0.1400 |
Capex 1 | 2.08 | 3.39 | 18 | 7.65 | 5.58 |
Capex / Sales | 2.5% | 4.01% | 17.05% | 6% | 7.59% |
Announcement Date | 29/11/22 | 29/11/22 | 29/11/22 | 24/04/23 | 26/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-10.34% | 30.72M | |
+24.02% | 88.39B | |
-22.99% | 75.6B | |
+3.24% | 26.87B | |
+4.74% | 17.81B | |
-12.13% | 16.85B | |
-0.23% | 15.31B | |
+77.70% | 13.53B | |
+80.98% | 13.48B | |
-24.56% | 13.01B |
- Stock Market
- Equities
- 1947 Stock
- Financials Meihao Medical Group Co., Ltd